Class IITerminatedD-0226-2017
Drug recall · December 28, 2016
AMGEN Kyprolis recall
Why: Lack of Assurance of Sterility: Potential cracks in glass vials
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
AMGEN Kyprolis (carfilzomib) for injection, 30 mg per vial, Discard unused portion, For Intravenous Administration Only, Rx Only, Manufactured for: Onyx Pharmaceuticals, Inc., Thousand Oaks, CA 91320-1799, U.S.A., NDC 76075-102-01
- Lots / codes
Lot #1071559, 1071629; Exp. 05/18
- Quantity
- 11,434 vials
- Company
- Amgen, Inc., Thousand Oaks, CA
- Distribution
- United States and Puerto Rico No foreign distribution.
- Initiated
- December 15, 2016 · Voluntary: Firm initiated
- Classified
- December 22, 2016
- Reported
- December 28, 2016
- Ended
- June 2, 2017
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.